Luis M. Vence

14.0k total citations · 4 hit papers
67 papers, 4.1k citations indexed

About

Luis M. Vence is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Luis M. Vence has authored 67 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 32 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Luis M. Vence's work include Cancer Immunotherapy and Biomarkers (41 papers), Immunotherapy and Immune Responses (24 papers) and CAR-T cell therapy research (17 papers). Luis M. Vence is often cited by papers focused on Cancer Immunotherapy and Biomarkers (41 papers), Immunotherapy and Immune Responses (24 papers) and CAR-T cell therapy research (17 papers). Luis M. Vence collaborates with scholars based in United States, Australia and Netherlands. Luis M. Vence's co-authors include Padmanee Sharma, James P. Allison, Jorge Blando, Laszlo Radvanyi, Sumit K. Subudhi, Jennifer A. Wargo, Hao Zhao, David Landry, Jack S. Benner and Jianjun Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Luis M. Vence

65 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element

1997 508 citations Luis M. Vence et al. profile →
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

2017 455 citations Jianjun Gao, Curtis A. Pettaway et al. Nature Medicine profile →
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

2014 416 citations Roberto Lande, Elisabetta Botti et al. Nature Communications profile →
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers

2018 266 citations Anu Sharma, Sumit K. Subudhi et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Luis M. Vence

Since Specialization

Citations

This map shows the geographic impact of Luis M. Vence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis M. Vence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis M. Vence more than expected).

Fields of papers citing papers by Luis M. Vence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis M. Vence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis M. Vence. The network helps show where Luis M. Vence may publish in the future.

Co-authorship network of co-authors of Luis M. Vence

This figure shows the co-authorship network connecting the top 25 collaborators of Luis M. Vence. A scholar is included among the top collaborators of Luis M. Vence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis M. Vence. Luis M. Vence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer 2020 ·Science Translational Medicine ·Sumit K. Subudhi, Luis M. Vence, Hao Zhao, Jorge Blando, Shalini S. Yadav, Qing Xiong, Alexandre Reuben, Ana M. Aparicio, Paul G. Corn, Brian F. Chapin, Louis L. Pisters, Patricia Troncoso, Rebecca S. Tidwell, Peter F. Thall, Chang‐Jiun Wu, Jianhua Zhang, (unknown), P. Andrew Futreal, James P. Allison, Padmanee Sharma	116
2	Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner 2019 ·Cancer Immunology Research ·Lewis Z. Shi, Sangeeta Goswami, Tihui Fu, Baoxiang Guan, Jianfeng Chen, Liangwen Xiong, Jan Zhang, Derek Ng Tang, Xuejun Zhang, Luis M. Vence, Jorge Blando, James P. Allison, (unknown), Jianjun Gao, Padmanee Sharma	35
3	Characterization and Comparison of GITR Expression in Solid Tumors 2019 ·Clinical Cancer Research ·Luis M. Vence, Samantha Bucktrout, Irina Fernandez Curbelo, Jorge Blando, (unknown), (unknown), John Lin, (unknown), Edward Pascua, Tao Sai, Javier Chaparro‐Riggers, Sumit K. Subudhi, Jorge Scutti, (unknown), Hao Zhao, Shalini S. Yadav, Anirban Maitra, Ignacio I. Wistuba, James P. Allison, Padmanee Sharma	38
4	Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma 2019 ·Nature Medicine ·Sangeeta Goswami, Thomas Walle, Andrew Cornish, Sreyashi Basu, Swetha Anandhan, Irina Fernandez, Luis M. Vence, Jorge Blando, Hao Zhao, Shalini S. Yadav, Martina Ott, Ling Yuan Kong, Amy B. Heimberger, John de Groot, Boris Sepesi, Michael J. Overman, Scott Kopetz, James P. Allison, Dana Pe’er, Padmanee Sharma	251
5	Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC 2019 ·Annals of Oncology ·Ahmed O. Kaseb, Luis M. Vence, Jorge Blando, Shalini S. Yadav, Naruhiko Ikoma, Roberto Carmagnani Pestana, J.N. Vauthey, Hop S. Tran Cao, (unknown), (unknown), Robert A. Wolff, James C. Yao, James P. Allison, Padmanee Sharma	14
6	Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers breakdown → 2018 ·Clinical Cancer Research ·Anu Sharma, Sumit K. Subudhi, Jorge Blando, Jorge Scutti, Luis M. Vence, Jennifer A. Wargo, James P. Allison, Antoni Ribas, Padmanee Sharma	266
7	Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination 2017 ·Cancer Research ·Hong Jiang, Yisel Rivera-Molina, Candelaria Gomez‐Manzano, Karen Clise-Dwyer, Laura Bover, Luis M. Vence, Ying Yuan, Frederick F. Lang, Carlo Toniatti, Mohammad B. Hossain, Juàn Fueyo	161
8	Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter 2017 ·Clinical Cancer Research ·Krit Ritthipichai, Cara Haymaker, (unknown), (unknown), Xiaohui Yi, Minying Zhang, (unknown), Luis M. Vence, Jason Roszik, Yared Hailemichael, Willem W. Overwijk, Navin Varadarajan, Roza Nurieva, Laszlo Radvanyi, Patrick Hwu, Chantale Bernatchez	54
9	4-1BB–Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells 2017 ·Cancer Immunology Research ·Michiko Harao, Marie-Andrée Forget, Jason Roszik, Hui Gao, Gildy V. Babiera, Savitri Krishnamurthy, Jessica Chacon, Shumin Li, Elizabeth A. Mittendorf, Sarah M. DeSnyder, (unknown), Chantale Bernatchez, Naoto T. Ueno, Laszlo Radvanyi, Luis M. Vence, Cara Haymaker, James M. Reuben	49
10	A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients 2017 ·Supportive Care in Cancer ·David R. Fogelman, Jeffrey S. Morris, Lianchun Xiao, Moustapha Hassan, (unknown), Michael J. Overman, (unknown), Rachna T. Shroff, Gauri R. Varadhachary, Robert A. Wolff, Luis M. Vence, Anirban Maitra, Charles S. Cleeland, (unknown)	24
11	P1.05-028 Phenotypic and Functional Profiling of Tumor-Infiltrating Lymphocytes (TIL) in Early Stage Non-Small Cell Lung Cancer (NSCLC) 2017 ·Journal of Thoracic Oncology ·Lorenzo Federico, Cara Haymaker, Marie‐Andrée Forget, Luis M. Vence, (unknown), Padmanee Sharma, James P. Allison, Bingliang Fang, Jianjun Zhang, Heidi Wagner, (unknown), Ignacio I. Wistuba, Boris Sepesi, John V. Heymach, Don L. Gibbons, Chantale Bernatchez	0
12	Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report 2016 ·Journal of Hematology & Oncology ·Marc Uemura, Van Anh Trinh, Cara Haymaker, Natalie Jackson, Dae Won Kim, James P. Allison, Padmanee Sharma, Luis M. Vence, Chantale Bernatchez, Patrick Hwu, Adi Diab	54
13	The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis breakdown → 2014 ·Nature Communications ·Roberto Lande, Elisabetta Botti, Camilla Jandus, Danijel Dojcinovic, Giorgia Fanelli, Curdin Conrad, Georgios Chamilos, Laurence Feldmeyer, Barbara Marinari, Susan Y. Chon, Luis M. Vence, Valeria Riccieri, (unknown), Alexander A. Navarini, Pedro Romero, Antonio Costanzo, Enza Piccolella, Michel Gilliet, Loredana Frasca	416
14	Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model 2014 ·PLoS ONE ·Hong Jiang, Karen Clise-Dwyer, Kathryn Ruisaard, Xuejun Fan, Weihua Tian, Joy Gumin, Martine L.M. Lamfers, Anne Kleijn, Frederick F. Lang, (unknown), Luis M. Vence, Candelaria Gomez‐Manzano, Juàn Fueyo	103
15	A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations 2014 ·Investigational New Drugs ·Elizabeth R. Plimack, Jayesh Desai, Jean‐Pierre J. Issa, Jaroslav Jelı́nek, Pradeep Sharma, Luis M. Vence, (unknown), (unknown), Nicholas E. Papadopoulos, Wen‐Jen Hwu	11
16	A New Approach to Simultaneously Quantify Both TCR α- and β-Chain Diversity after Adoptive Immunotherapy 2012 ·Clinical Cancer Research ·Minying Zhang, Sourindra N. Maiti, Chantale Bernatchez, Helen Huls, Brian Rabinovich, Richard E. Champlin, Luis M. Vence, Patrick Hwu, Laszlo Radvanyi, Laurence J.N. Cooper	15
17	BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency 2012 ·Clinical Cancer Research ·David S. Hong, Luis M. Vence, Gerald S. Falchook, Laszlo Radvanyi, Chengwen Liu, Vicki Goodman, Jeffery J. Legos, (unknown), (unknown), Razelle Kurzrock, Gregory Lizée, Patrick Hwu	82
18	Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients 2012 ·Bone Marrow Transplantation ·Myriam Foglietta, Sattva S. Neelapu, Larry W. Kwak, Ying Jiang, (unknown), (unknown), Daniel H. Fowler, Claude Sportès, R E Gress, S. M. Steinberg, Luis M. Vence, Laszlo Radvanyi, Karen C. Dwyer, M. Qazilbash, (unknown), Michael R. Bishop	9
19	Presurgical Stress Management Improves Postoperative Immune Function in Men With Prostate Cancer Undergoing Radical Prostatectomy 2011 ·Psychosomatic Medicine ·Lorenzo Cohen, Patricia A. Parker, Luis M. Vence, (unknown), (unknown), Curtis A. Pettaway, Richard J. Babaian, Louis L. Pisters, Brian J. Miles, Qi Wei, (unknown), (unknown), Laszlo Radvanyi	53
20	Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast 2010 ·Cancer ·Henry M. Kuerer, Aman U. Buzdar, Elizabeth A. Mittendorf, Francisco J. Esteva, Anthony Lucci, Luis M. Vence, Laszlo Radvanyi, Funda Meric‐Bernstam, Kelly K. Hunt, W. Fraser Symmans	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact